Sign In
Buy RHHBY
$49.15
-0.610 (-1.23%)
At Close: Jun 22, 2026
Basel, 10 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented an exploratory analysis from the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab), compared with observatio
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
01:00am, Wednesday, 09'th Dec 2020
Basel, 9 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna's mRNA-1273 vaccine rese
How You Can Profit From the Best-Managed Drugmaker on Earth
06:30am, Tuesday, 08'th Dec 2020
One metric shows that decades of dominance treating diabetes has created unrivaled profitability.
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
01:00am, Tuesday, 08'th Dec 2020
Basel, 08 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data on its investigational T-cell engaging bispecific antibodies, mosunetuzumab, glofitamab and cevostamab, were
Covid Tests And New Drugs To Drive Roche's Stock Growth
08:30am, Monday, 07'th Dec 2020
Roche's ADR is up just 2% since the start of the year and it has gained around 20% from its March lows. Despite the recent run, Roche could offer an upside in the near term, as the company's revenues
Basel, 07 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced longer-term data from the pivotal phase Ib/II GO29365 study, including data from a single-arm extension cohort of 106 addit
New follow-up phase III data reinforce the long-term benefit of Roche's Hemlibra for people with haemophilia A
01:00am, Monday, 07'th Dec 2020
Basel, 7 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from a new analysis of pooled, three-year follow-up data of 401 people with haemophilia A from the pivotal HAVEN 1-4
Basel, 5 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from the pivotal phase III MURANO and CLL14 studies support the efficacy of fixed-d
Roche's coronavirus antibody test gets emergency use authorization from the U.S.
03:01am, Wednesday, 02'nd Dec 2020
Roche has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for a new test that measures levels of Covid-19 antibodies.
Basel, 2 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto™ (pralsetinib) for the treatment of adult and paedia
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
01:00am, Wednesday, 02'nd Dec 2020
Basel, 2 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the U.S. Food and Dru
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto
FDA approves Xolair® (omalizumab) for adults with nasal polyps
12:07pm, Tuesday, 01'st Dec 2020
Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologi
Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal Polyps
11:34am, Tuesday, 01'st Dec 2020
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the com
Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies
11:30am, Tuesday, 01'st Dec 2020
INDIANAPOLIS, Dec. 1, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the
